Swedish Healthtech Stock News

As the European market navigates a landscape marked by mixed stock index performances and economic indicators, investor attention is drawn to growth companies with strong insider ownership, particularly those anticipating revenue growth. In such an environment, stocks that combine robust internal stakeholder commitment with promising expansion prospects can offer intriguing opportunities for investors seeking resilience and potential in their portfolios.

Saab (OM:SAAB B) just hit an interesting milestone with Divergent Technologies, delivering initial autonomous aircraft fuselages built using fully digital, additive manufacturing. For investors, this is less about near term revenue and more about long term capability. See our latest analysis for Saab. That milestone with Divergent lands after a busy spell for Saab, with fresh Spanish Army training contracts and another Lithuanian MSHORAD order. It comes on top of a powerful year to date share...

Betsson AB has completed the conditions for early redemption of its 2023/2026 bonds following the issuance of new debt on 4 December 2025, while also continuing its share buyback programme that repurchased 125,000 series B shares in early December under a planned total of up to €40 million by April 2026. Together, the debt refinancing and ongoing buybacks highlight Betsson’s current focus on capital structure optimisation and returning excess cash to shareholders while maintaining financial...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Beijer Alma fair value estimate is kr331 With kr277 share...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") above 23x, you may consider...

DistIT AB (publ)'s ( STO:DIST ) price-to-sales (or "P/S") ratio of 0.1x might make it look like a buy right now...

Key Insights Dometic Group's estimated fair value is kr88.96 based on 2 Stage Free Cash Flow to Equity Dometic Group is...

With a price-to-earnings (or "P/E") ratio of 27.9x AVTECH Sweden AB (publ) ( STO:AVT B ) may be sending bearish signals...

Key Insights Significant control over Cibus Nordic Real Estate by retail investors implies that the general public has...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Fable Media Group AB ( NGM:FABLE ) stock is about to trade ex-dividend in three days. Typically, the ex-dividend date...

Key Insights Institutions' substantial holdings in Trelleborg implies that they have significant influence over the...

Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...

Whilst it may not be a huge deal, we thought it was good to see that the Humble Group AB (publ) ( STO:HUMBLE ) Chief...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Clas Ohlson (OM:CLAS B) has just posted another solid quarter, with Q2 2026 revenue of SEK3.0 billion and basic EPS of SEK4.85, backed by net income of SEK308.3 million. The company has seen revenue move from SEK2.8 billion and EPS of SEK3.63 in Q2 2025 to SEK3.0 billion and EPS of SEK4.85 in Q2 2026. On a trailing twelve month basis, EPS sits at SEK16.11 on revenue of SEK12.0 billion and net income of SEK1.0 billion, giving investors a clear picture of sustained earnings power. Overall, the...

Peab (OM:PEAB B) just added two meaningful Swedish contracts to its pipeline: a SEK 177 million retirement home in Falun and a SEK 113 million fossil free infrastructure project in Stockholm's Meatpacking District. See our latest analysis for Peab. These fresh contracts land at a time when sentiment around Peab has been gradually improving, with the share price up 6.76 percent over the past month and a punchy 56.31 percent three year total shareholder return. This suggests momentum is quietly...

BONESUPPORT has already shifted its U.S. regulatory route for CERAMENT V for bone infection from a 510(k) submission to the FDA’s De Novo pathway, extending the formal review period from 90 to 150 days while transferring substantial existing clinical and pharmacological documentation. This move suggests CERAMENT V could, if cleared, create a new product category in the U.S., echoing how CERAMENT G previously established a distinct regulatory class and potentially underscoring the uniqueness...

Investor (OM:INVE A) has appointed Ulrika Elfving as its new General Counsel and Executive Leadership Team member, a governance focused move that could subtly shape risk management and long term value creation. See our latest analysis for Investor. The market seems to be taking this leadership change in its stride. The latest share price is SEK 318.8, and a solid 90 day share price return of 11.55 percent is backing up a strong multi year total shareholder return profile. This suggests that...

Cloetta (OM:CLA B) just took a tangible step into the U.S. candy aisle, with subsidiary CandyKing opening a permanent Swedish Candy store in New York City, a move worth watching for long term brand building. See our latest analysis for Cloetta. That New York foothold comes on the back of strong momentum, with a roughly 13 percent 1 month share price return and a near 52 percent year to date share price gain. Long term total shareholder returns above 100 percent hint investors already see...

Norion Bank (OM:NORION) just bought back another 2 million shares under its SEK 500 million repurchase program, lifting its treasury stake to over 5% and sharpening the focus on capital allocation. See our latest analysis for Norion Bank. The timing of this latest repurchase lines up with solid momentum, with a roughly 79% year to date share price return and a 73% one year total shareholder return suggesting the market is steadily rewarding Norion Bank’s story rather than chasing a short term...

Wondering if Skanska is still good value after its run over the last few years, or if most of the upside is already priced in? This breakdown will help you decide whether to keep watching or start acting. The stock has climbed about 2.0% over the last week, 3.3% year to date and 9.3% over the past year, while its 3 year gain of 60.9% and 5 year gain of 44.6% show that investors have already been rewarded for backing the story. Recent headlines have focused on Skanska winning new...

Fabege (OM:FABG) has retained its Nasdaq Green Equity label for a third year, backed by an S&P Global Ratings review. This serves as a fresh reminder that most of its business and investments are genuinely tied to green activities. See our latest analysis for Fabege. The recognition comes as Fabege’s share price sits at SEK 80.45, with a modest 90 day share price return of 1.20 percent but a five year total shareholder return of negative 28.79 percent. This suggests momentum is only slowly...